Menopause Review (Feb 2010)

Przyczyny niepowodzeń leczenia chorych na raka trzonu macicy poddanych pooperacyjnej radioterapii

  • Michał Spych,
  • Leszek Gottwald,
  • Emilia Jesień-Lewandowicz,
  • Justyna Chałubińska,
  • Janusz Sobotkowski,
  • Jacek Fijuth

Journal volume & issue
Vol. 14, no. 1
pp. 32 – 37

Abstract

Read online

Introduction: The treatment of choice for patients with early clinical stage uterine cancer is surgical intervention.In complementary treatment in standard use is radiotherapy (teletherapy and brachytherapy). In case of onset of disease recurrence, salvage treatment frequently proves ineffective, which is connected with a highpercent of deaths in this group of patients. The aim was to evaluate the causes of treatment failure in patients with endometrial cancer treated withpostoperative radiotherapy. Material and methods: Twenty-eight patients aged between 49 and 84 years were enrolled in the study,in whom for the period from 2002 until 2004 postoperative radiotherapy was applied, and in whom during theperiod of five years after treatment termination disease recurrence was observed. Results: In the analyzed group of patients the 2- and 4-year disease-free survival (DFS) was 41% and 11%respectively. The 2- and 5-year overall survival (OS) was 67% and 13%. Locoregional failures occurred in 5 (17.7%)patients. Distant metastases were detected in 15 (63.6%) patients. In 8 (28.6%) patients, distant metastases occurredsimultaneously with local relapse. Neither of the treatment methods after disease recurrence significantlyextended the survival of patients (p = 0.82). Patients’ age was the sole prognostic factor which has a statisticallysignificant impact on DFS. On the other hand an adverse affect on overall survival was demonstrated for thevariable of the time of disease recurrence. In the group of patients in whom the recurrence was demonstratedearlier than 6 months after treatment termination the OS was significantly shorter (p = 0.001). Conclusions: Distant metastases are the main cause of failures of patients’ treatment for endometrioidendometrial cancer. Neither of the treatment methods after disease recurrence significantly extended the survivalof patients. Shorter time to disease recurrence is a negative prognostic factor with reference to overallsurvival.

Keywords